Cite
HARVARD Citation
Masaba, R. et al. (2018). Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission. AIDS. p. . [Online].